Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90

Detalles Bibliográficos
Autores principales: Feraco, Angela M., Zhou, Yiwang, Zheng, Ying, Marks, Lianna J., Friedmann, Alison, Weinstein, Howard J., Link, Michael P., Flerlage, Jamie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637876/
https://www.ncbi.nlm.nih.gov/pubmed/37647596
http://dx.doi.org/10.1182/bloodadvances.2023010944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637876/
https://www.ncbi.nlm.nih.gov/pubmed/37647596
http://dx.doi.org/10.1182/bloodadvances.2023010944

Ejemplares similares